Why the Certificate of Analysis Is Your First Experimental Control
Every lot of synthetic research peptide ships with a Certificate of Analysis (COA). For many researchers, this document is glanced at briefly and then filed away. That habit can undermine experimental reproducibility before a single assay is run. The COA is the primary document linking the physical material in your freezer to the analytical data generated during its manufacture. Understanding each field allows you to judge whether a peptide lot is fit for the specific assay you are running—and to flag potential sources of variability when results deviate from expectations.
This guide walks through the standard sections of a research-peptide COA in the order they typically appear, explaining what each value means, what acceptable ranges look like for most research applications, and what questions to ask when something looks unusual.
Lot and Batch Identification
The top section of any COA carries identifiers that connect the document to a specific manufacturing run. Key fields include:
- Catalog number and peptide name: Confirm the sequence or common name matches what you ordered. Vendors that supply both the single-letter sequence and the full IUPAC name give you the clearest confirmation.
- Lot or batch number: This number must match the label on the vial. If they differ, contact the supplier before opening the vial—the analytical data may not describe the material in hand.
- Molecular weight (calculated): The theoretical MW derived from the amino acid composition. This serves as the reference value for mass spectrometry confirmation.
- Net peptide content (NPC) or peptide content percentage: Sometimes listed here; more often reported alongside moisture data (see below).
Purity by HPLC
High-performance liquid chromatography (HPLC) purity is the single most cited quality metric for synthetic peptides, and it deserves careful interpretation.
What HPLC purity actually measures
Reverse-phase HPLC separates peptide species by hydrophobicity. The detector—almost always a UV detector set at 214 nm or 220 nm—measures absorbance as each species elutes. Purity is reported as the percentage of total peak area attributed to the main product peak. Critically, this is a relative measure. Species that do not absorb at the detector wavelength (residual solvents, salts, water) are invisible to UV detection. Deletion sequences or truncated fragments that closely resemble the target peptide will, however, appear as distinct shoulders or peaks.
Interpreting the reported value
For most biochemical binding or cell-free assays, a purity of ≥95% (area under the curve, or AUC) is considered acceptable. Structural studies—particularly NMR or crystallography—often require ≥98%. Assays sensitive to trace contaminants may require additional scrutiny of the chromatogram itself, not just the headline number. Always ask for, or download, the actual chromatogram. A clean 97% trace with one minor impurity peak is very different from a 97% trace showing a broad, unresolved shoulder, which may indicate multiple co-eluting truncation products.
Column and method conditions
A rigorous COA lists the HPLC column type (e.g., C18 stationary phase), gradient conditions, and flow rate. This allows an independent laboratory to replicate the measurement. If method conditions are absent, reproducibility of the purity claim cannot be verified.
Mass Spectrometry Confirmation
Mass spectrometry (MS) confirms molecular identity—that the peptide synthesized matches the intended sequence—but it does not independently confirm purity. Common ionization methods reported on peptide COAs include electrospray ionization (ESI-MS) and matrix-assisted laser desorption/ionization (MALDI-MS).
The COA should report:
- Observed m/z value(s): Because ESI produces multiply charged ions, you will often see multiple charge states (e.g., [M+2H]²⁺, [M+3H]³⁺). Each should back-calculate to the same neutral mass.
- Calculated molecular weight: The theoretical monoisotopic or average mass derived from the sequence.
- Mass accuracy: A discrepancy of ±1 Da or less (for average masses) is typical and acceptable. Larger discrepancies may indicate sequence errors, missed deprotection, or adduct formation and warrant follow-up.
A peptide can pass mass confirmation while still containing significant impurities at the same nominal mass (e.g., diastereomers or oxidation products at equivalent mass). Mass confirmation and HPLC purity together provide meaningful identity and quality assurance—neither alone is sufficient.
Moisture and Counterion Content
Lyophilized peptides are hygroscopic and typically contain residual water. The raw weight in the vial therefore includes both peptide and water. Moisture content is measured by Karl Fischer titration, a coulometric method that quantifies water directly.
The net peptide content (NPC) corrects the gross weight for both moisture and counterion (typically trifluoroacetate, TFA, or acetate from the final lyophilization step). For example, a vial labeled as containing 5 mg with a reported NPC of 75% contains approximately 3.75 mg of actual peptide on a molar basis. Failing to account for NPC when preparing stock solutions introduces systematic concentration errors that compound across all downstream experiments.
Some suppliers report TFA content separately; others fold it into a combined NPC figure. Either approach is valid provided the arithmetic is transparent and traceable on the COA.
Storage Conditions and Reconstitution Notes
A complete COA includes recommended storage conditions (temperature, light exposure, desiccation) and, ideally, suggested reconstitution solvents. These recommendations are sequence-dependent—hydrophobic peptides may require DMSO or dilute acetic acid, while hydrophilic sequences dissolve readily in aqueous buffers. Improper reconstitution can cause aggregation that mimics biological activity or masks it entirely. Storage conditions affect shelf life; peptides containing methionine, cysteine, or tryptophan residues are particularly susceptible to oxidative degradation over time.
Synthesizer and Analyst Sign-Off
A professionally issued COA will carry the name or initials of the analyst who performed the testing, a date of analysis, and often a QC manager approval signature. These fields establish a traceable chain of custody from synthesis to characterization to shipment. In regulated-adjacent research contexts—such as studies submitted to funding agencies or published alongside primary data—this traceability supports the reproducibility of reported findings.
Using the COA to Troubleshoot Assay Variability
When experimental results are inconsistent across lots, the COA is the logical first diagnostic resource. Compare purity values between lots; even a shift from 98% to 95% can alter assay signal if the 3% impurity fraction has biological activity. Compare NPC values to ensure that stock concentrations prepared by mass were equivalent on a molar basis. Check whether different lots were synthesized with different counterions, as TFA can itself be cytotoxic at sufficient concentrations in cell-based assays and may need to be exchanged before use.
Summary Checklist for COA Review
- Lot number on document matches lot number on vial label
- Peptide sequence or name confirmed against order
- HPLC purity ≥ threshold required for the intended assay
- Chromatogram reviewed (not just the headline purity number)
- HPLC method conditions documented (column, gradient, wavelength)
- MS observed mass within ±1 Da of calculated mass
- Net peptide content reported and applied to concentration calculations
- Storage and reconstitution conditions noted before opening the vial
- Analyst name, date of analysis, and QC approval present
For research use only. The information presented in this article is intended exclusively for qualified laboratory researchers working in appropriate research settings. This material is not intended for diagnostic, therapeutic, or any human or veterinary use. Always follow institutional biosafety guidelines and applicable regulations when handling research chemicals.